Christoph U. Correll, MD
Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York, Department of Psychiatry and Molecular Medicine Hempstead, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany
Insights
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
August 17, 2022
Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
Academic Highlights
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
August 17, 2022
Many people with schizophrenia feel isolated and disengaged from their own lives even when symptoms are under control. Here, experts discuss assessment of life engagement and treatment strategies that...
Academic Highlights
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
August 3, 2022
Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
Review Article
Outcomes of NMS With Depot Versus Oral Antipsychotics
November 24, 2020
Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...
